Atorvastatin Calcium
Product Images NDC 60760-829

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 60760-829). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

829-30 (Atorvastatin 829 30)

Atorvastatin Calcium 40mg tablets label showing prescription medication details including quantity (30), NDC 60760-829-30, manufacturer Sun Pharmaceutical Industries Limited, and packager St. Mary's Medical Park Pharmacy in Oro Valley, AZ. The label includes usage instructions, storage conditions, and several placeholder fields for lot number, expiration date, and RX number.*

FDA Label Image

Structure (Image 01)

Chemical structure of Atorvastatin Calcium, showing its molecular framework including phenyl rings, fluorophenyl group, hydroxyl groups, and calcium ion complexation with hydration waters.*

FDA Label Image

Figure1 (Image 02)

A line graph comparing the cumulative incidence (%) over time (years) between Atorvastatin and placebo groups. The solid line represents Atorvastatin, and the dashed line represents placebo, showing a lower cumulative incidence in the Atorvastatin group throughout approximately 3.5 years. Hazard ratio and p-value are noted in the lower right corner.*

FDA Label Image

Figure 2 (Image 03)

A line graph comparing the cumulative hazard percentage over a five-year period for Atorvastatin versus placebo. The solid line represents Atorvastatin, showing a consistently lower cumulative hazard compared to the dashed line for placebo. The x-axis shows time to first primary endpoint in years, and the y-axis shows cumulative hazard percentage. Statistical data includes hazard ratio (HR) 0.63 with a confidence interval of 0.48-0.83 and p-value of 0.001.*

FDA Label Image

Figure 3 (Image 04)

A line graph showing the percentage of subjects experiencing a major cardiovascular event over time, comparing Atorvastatin 10 mg and 80 mg doses. The x-axis represents time in years, and the y-axis represents the percentage of subjects. The graph includes a hazard ratio (HR) of 0.78 with confidence intervals and a p-value.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.